Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | ALKBH1 | Q13686 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 3/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31664992 | 0.91 | KDM1A (0.46) | MAPTRAB9AL3MBTL1KDM1ACASP3 | |
| SCHEMBL21816553 | 0.85 | RAB9A (0.43) | MAPTRAB9AL3MBTL1CASP3SENP8 | |
| SCHEMBL9061973 | 0.85 | RAB9A (0.52) | MAPTRAB9AL3MBTL1CASP3SENP8 | |
| SCHEMBL21816578 | 0.85 | RAB9A (0.43) | MAPTRAB9AL3MBTL1CASP3SENP8 | |
| SCHEMBL21816576 | 0.82 | RAB9A (0.44) | MAPTRAB9AL3MBTL1CASP3SENP8 | |
| SCHEMBL9062033 | 0.82 | RAB9A (0.57) | MAPTRAB9AL3MBTL1CASP3SENP8 | |
| SCHEMBL9062359 | 0.80 | RAB9A (0.65) | MAPTRAB9AL3MBTL1CASP3SENP8 | |
| SCHEMBL8019903 | 0.80 | CASP3 (0.64) | MAPTRAB9AL3MBTL1KDM1ACASP3 | |
| SCHEMBL9060886 | 0.79 | RAB9A (0.71) | MAPTRAB9AL3MBTL1CASP3SENP8 | |
| SCHEMBL1550145 | 0.79 | CHRM5 (0.46) | MAPTRAB9AL3MBTL1KDM1ACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240389588-A1 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-11-28 | — | — | US | disclosed |
| US-12022832-B2 | Compounds and methods for treating nematode infections | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-07-02 | — | — | US | disclosed |
| US-20220354117-A1 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2022-11-10 | — | — | US | disclosed |
| WO-2020051689-A1 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2020-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12022832-B2 | Compounds and methods for treating nematode infections | HNMT, NISCH, HRH2 | MAPT 3317/4885RAB9A 2708/4885L3MBTL1 2062/4885 |
| US-20220354117-A1 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | HNMT, NISCH, HRH2 | MAPT 3317/4885RAB9A 2708/4885L3MBTL1 2062/4885 |
| US-20240389588-A1 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | HNMT, NISCH, HRH2 | MAPT 3317/4885RAB9A 2708/4885L3MBTL1 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.